Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wolf, C. J.
Right arrow Articles by Gray, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, C. J.
Right arrow Articles by Gray, L. E., Jr.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 55, 152-161 (2000)
Copyright © 2000 by the Society of Toxicology


Reproductive and Developmental Toxicology

Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin

Cynthia J. Wolf*,{dagger}, Gerald A. LeBlanc{dagger}, Joseph S. Ostby* and L. Earl Gray, Jr.*,1

* Endocrinology Branch, MD 72, Reproductive Toxicology Division, Endocrinology Branch, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711; and {dagger} Department of Toxicology, North Carolina State University, Raleigh, North Carolina 27695

Vinclozolin is a fungicide whose metabolites are androgen receptor (AR) antagonists. Previous work in our laboratory showed that perinatal administration of vinclozolin to rats results in malformations of the external genitalia, permanent nipples, reduced anogenital distance (AGD), and reduced seminal vesicle, ventral prostate, and epididymal weights. The objectives of this study were to determine the most sensitive period of fetal development to antiandrogenic effects of vinclozolin and to identify a dosing regime that would induce malformations in all of the male offspring. Pregnant rats were dosed with 400 mg vinclozolin/kg/day on either GD 12–13, GD 14–15, GD 16–17, GD 18–19, or GD 20–21, or with corn oil (2.5 ml/kg) from GD 12 through GD 21 (Experiment 1). All 2-day periods in which significant effects were produced were included in an extended dosing period, GD 14 through GD 19, in which pregnant rats were dosed with 200 or 400 mg vinclozolin/kg (Experiment 2). In Experiment 1, significant effects of vinclozolin were observed in rats dosed on gestation days (GD) 14–15, GD 16–17, and GD 18–19, while the most significant effects were observed in rats treated on GD 16–17. These effects include reduced AGD; presence of areolas, nipples, and malformations of the phallus; and reduced levator ani/bulbocavernosus weight. In contrast, ventral prostate weight was reduced only in the GD 18–19 group. The expanded dosing regime (Experiment 2) increased the percentage of male offspring with genital malformations (> 92%), and retained nipples (100%), further reduced the weight of the ventral prostate, and reduced the weight of the seminal vesicles. In addition, malformations were more severe and included vaginal pouch and ectopic/undescended testes. The latter was induced only in the 400 mg/kg group. These data indicate that the reproductive system of the fetal male rat is most sensitive to antiandrogenic effects of vinclozolin on GD 16 and 17, although effects are more severe and 100 % of male offspring are affected with administration of vinclozolin from GD 14 through GD 19.

Key Words: vinclozolin; antiandrogen; androgen receptor; male reproductive development; critical period; levator ani; hypospadias; anogenital distance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
C. V. Rider, V. S. Wilson, K. L. Howdeshell, A. K. Hotchkiss, J. R. Furr, C. R. Lambright, and L. E. Gray Jr
Cumulative Effects of In Utero Administration of Mixtures of "Antiandrogens" on Male Rat Reproductive Development
Toxicol Pathol, January 1, 2009; 37(1): 100 - 113.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Sierra-Santoyo, G. Castaneda-Hernandez, R. A. Harrison, H. A. Barton, and M. F. Hughes
Pharmacokinetics and Dosimetry of the Antiandrogen Vinclozolin after Oral Administration in the Rat
Toxicol. Sci., November 1, 2008; 106(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Biggs, M. D. Davis, D. L. Eaton, N. S. Weiss, D. B. Barr, D. R. Doody, S. Fish, L. L. Needham, C. Chen, and S. M. Schwartz
Serum Organochlorine Pesticide Residues and Risk of Testicular Germ Cell Carcinoma: A Population-Based Case-Control Study
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2012 - 2018.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease
Reproduction, May 1, 2008; 135(5): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Welsh, P. T. K. Saunders, and R. M. Sharpe
The Critical Time Window for Androgen-Dependent Development of the Wolffian Duct in the Rat
Endocrinology, July 1, 2007; 148(7): 3185 - 3195.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
R P Amann and D N R Veeramachaneni
Cryptorchidism in common eutherian mammals
Reproduction, March 1, 2007; 133(3): 541 - 561.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. D. Anway, C. Leathers, and M. K. Skinner
Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease
Endocrinology, December 1, 2006; 147(12): 5515 - 5523.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H.-S. Chang, M. D. Anway, S. S. Rekow, and M. K. Skinner
Transgenerational Epigenetic Imprinting of the Male Germline by Endocrine Disruptor Exposure during Gonadal Sex Determination
Endocrinology, December 1, 2006; 147(12): 5524 - 5541.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. T. Sanderson
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Toxicol. Sci., November 1, 2006; 94(1): 3 - 21.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. D. Anway, M. A. Memon, M. Uzumcu, and M. K. Skinner
Transgenerational Effect of the Endocrine Disruptor Vinclozolin on Male Spermatogenesis
J Androl, November 1, 2006; 27(6): 868 - 879.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A Bozec, F Chuzel, S Chater, C Paulin, R Bars, M Benahmed, and C Mauduit
The mitochondrial-dependent pathway is chronically affected in testicular germ cell death in adult rats exposed in utero to anti-androgens
J. Endocrinol., October 1, 2004; 183(1): 79 - 90.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. S Fisher
Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome
Reproduction, March 1, 2004; 127(3): 305 - 315.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. Wolf, G. A. LeBlanc, and L. E. Gray Jr.
Interactive Effects of Vinclozolin and Testosterone Propionate on Pregnancy and Sexual Differentiation of the Male and Female SD Rat
Toxicol. Sci., March 1, 2004; 78(1): 135 - 143.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. E. Aldridge, J. A. Gibbons, M. M. Flaherty, M. L. Kreider, J. A. Romano, and E. D. Levin
Heterogeneity of Toxicant Response: Sources of Human Variability
Toxicol. Sci., November 1, 2003; 76(1): 3 - 20.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Omezzine, S. Chater, C. Mauduit, A. Florin, E. Tabone, F. Chuzel, R. Bars, and M. Benahmed
Long-Term Apoptotic Cell Death Process with Increased Expression and Activation of Caspase-3 and -6 in Adult Rat Germ Cells Exposed in Utero to Flutamide
Endocrinology, February 1, 2003; 144(2): 648 - 661.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Y. Euling, C. Gennings, E. M. Wilson, J. A. Kemppainen, W. R. Kelce, and C. A. Kimmel
Response-Surface Modeling of the Effect of 5{alpha}-Dihydrotestosterone and Androgen Receptor Levels on the Response to the Androgen Antagonist Vinclozolin
Toxicol. Sci., October 1, 2002; 69(2): 332 - 343.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. J. Wolf, A. Hotchkiss, J. S. Ostby, G. A. LeBlanc, and L. E. Gray Jr.
Effects of Prenatal Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response Study
Toxicol. Sci., January 1, 2002; 65(1): 71 - 86.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. E. Gray Jr., J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni, and L. Parks
Perinatal Exposure to the Phthalates DEHP, BBP, and DINP, but Not DEP, DMP, or DOTP, Alters Sexual Differentiation of the Male Rat
Toxicol. Sci., December 1, 2000; 58(2): 350 - 365.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.